Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vermon is a privately held French medical device company focused on the design and manufacture of customized ultrasound transducers, arrays, and probes for medical imaging applications. Founded in 1984 in Tours, France, the company supplies OEM and custom probe solutions spanning radiology, cardiovascular, OB/GYN, urology, surgery, musculoskeletal, and research use cases. Vermon positions itself as an independent ultrasound technology specialist with core capabilities in piezocomposite, single-crystal, and MEMS-based transducer technologies including CMUT and PMUT. The company also operates broader industrial ultrasound activities through Vermon Group, but its healthcare relevance is centered on commercial ultrasound probe and transducer products rather than therapeutic drug development. Vermon appears to be a mature commercial-stage medtech manufacturer with substantial in-house R&D, engineering, and production capabilities in France and the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vermon.